LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven herbal products for heart and brain health, has announced results preliminary unaudited for the first quarter ended March 31, 2022.
Net revenue for the first quarter is expected to total more than $489,000, up 187% from the same quarter a year ago, and maintains the full-year outlook of revenue doubling to over $3 million.
“Our record first-quarter revenue was driven primarily by direct-to-consumer channel expansion, including a four-fold increase in recurring product subscription revenue,” said Duke Pitts, president of Healthy Extracts. “We also expect this strong performance to propel our first-ever positive net profit quarter.”
Over the past year, the company has established a solid foundation to address the rapidly growing market for brain and heart health supplements, including key acquisitions and successful clinical studies that support health claims. the health of its products.
“We believe that the progress we have made, particularly with the expansion of our sales channels and our portfolio of clinically proven natural products, keeps us on track for our guided sales growth of 100% in 2022” , added Duke. “In addition to our continued focus on building our recurring revenue stream from subscriptions, we expect continued strengthening of our shareholder value throughout the year.”
Preliminary unaudited results are estimates only and are subject to revision until the Company releases its financial results for the first quarter ended March 31, 2022, which it expects to release in May.
About Healthy Extracts “Relive the Young Life”
Healthy Extracts Inc. is a platform for the development or acquisition of scientifically and clinically proven proprietary herbal products in select high growth categories within the multi-billion dollar nutraceutical market.
The Company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer natural nutraceutical supplements for heart and brain health. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known to have the highest quality and concentration of polyphenols and flavonoids, and with heart-healthy benefits backed by over 17 clinical studies.
UBN KETONOMICS® proprietary formulations have been clinically shown to improve brain health, including memory, cognition, focus and neuro-energy. UBN seeks IP licensing opportunities to monetize its IP portfolio consisting of several issued and pending patents.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements and Safe Harbor Notices
All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). These forward-looking statements include our expectations and statements that use forward-looking words such as “expected”, “expected”, “possibility” and “anticipate”. The realization or success of the matters covered by these forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the company’s annual report on Form 10-K filed with the SEC on April 1, 2022 and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that the statements and assumptions made in this press release constitute forward-looking statements and do not guarantee future performance. Forward-looking statements are based on management’s estimates and opinions at the time the statements are made. The information presented here is only valid as of the date hereof. The Company and its management do not undertake to revise these statements after the date of this press release.
Food and Drug Administration Disclosure
The product and formulation shown in this release is not intended for use or sale to persons under the age of 12. This product should be used only as directed on the label. Consult a physician before use if you have a serious medical condition or are using prescription medication. A doctor’s advice should be sought before using this product and any dietary supplement. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™
Healthy Extracts Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Ronald Both or Justin Lumley
Tel (949) 432-7566
Tel (949) 432-7572